Osimertinib Active Not Recruiting Phase 1 / 2 Trials for Advanced Non Small Cell Lung Cancer / Advanced (Inoperable) Non Small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT02143466AZD9291 in Combination With Ascending Doses of Novel Therapeutics